Our previous data also verified that PTEN is a candicate direct target gene by miR-19a/b, which is consistent with the results for breast cancer and T-cell lymphoma [10, 17, 18]. This evidence concerns the gene PTEN and T-cell non-Hodgkin lymphoma.